Skip to main content
Optomed Oyj logo

Optomed Oyj — Investor Relations & Filings

Ticker · OPTOMED ISIN · FI4000410881 LEI · 7437009IVYWGEE4S7B77 HE Manufacturing
Open in API
Filings indexed 613 across all filing types
Latest filing 2026-05-08 Regulatory Filings
Country FI Finland
Listing HE OPTOMED

About Optomed Oyj

https://www.optomed.com/

Optomed is a medical technology company that develops, commercializes, and manufactures handheld fundus cameras and related artificial intelligence (AI) solutions. The company specializes in portable retinal imaging devices designed for the early detection of blinding eye diseases, such as diabetic retinopathy, and other health conditions. Its technology combines portable hardware with AI-powered software to provide real-time analysis and results, enabling comprehensive eye screenings in various healthcare settings, from primary care clinics to emergency rooms. The solutions are designed to integrate into existing clinical workflows, improving access to eye care and transforming routine screenings into comprehensive health assessments.

Recent filings

Filing Released Lang Actions
Optomedin hallituksen järjestäytymiskokouksen päätöksiä
Regulatory Filings
2026-05-08 Finnish
Decisions of the Organization Meeting of Optomed's Board of Directors
Regulatory Filings
2026-05-08 English
Decisions of the Annual General Meeting
Regulatory Filings
2026-05-08 English
Optomedin varsinaisen yhtiökokouksen päätöksiä
Regulatory Filings
2026-05-08 Finnish
05068906.pdf
Interim / Quarterly Report Classification · 100% confidence The document is titled 'Osavuosikatsaus Tammi - Maaliskuu 2026' which translates to 'Interim Report January - March 2026'. It contains detailed financial data for the first quarter of 2026, including revenue, operating profit, segment performance, cash flow, and outlook. The document includes comprehensive financial tables, management commentary, and segment analysis. It also mentions a conference call for analysts and investors, which is typical for quarterly earnings releases. The length of the document (15,000 characters) and the presence of substantive financial data and analysis confirm it is a full interim/quarterly report rather than a brief earnings release or announcement. Therefore, the document fits the definition of an Interim / Quarterly Report (IR).
2026-05-06 Finnish
Optomed Oyj:n Osavuosikatsaus, tammi-maaliskuu 2026
Interim / Quarterly Report Classification · 100% confidence The document is titled 'Optomed Oyj:n Osavuosikatsaus, tammi-maaliskuu 2026', which translates to 'Interim Report, January-March 2026'. It contains detailed financial data for the first quarter of 2026, including revenue, operating profit, segment performance, cash flow, and outlook. The document is about 15,000 characters long, indicating it is a full report rather than a brief announcement. It includes comprehensive financial statements and management commentary for a period shorter than a full fiscal year, consistent with an Interim / Quarterly Report. There is no indication that this is merely an announcement or a certification, nor is it a full annual report or earnings release. Therefore, the document fits the definition of an Interim / Quarterly Report (IR).
2026-05-06 Finnish

Browse filings by year

8 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.